Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
The Journal of Biological Chemistry|December 3, 2014
miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2Yi Lin, Dengju Li, Qing Liang, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2025
Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHLGaoxiang Wang, Meijuan Huang, Lijun Jiang, et al.Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|December 14, 2004
Clinical observation of patients with hematologic malignancies treated with hematopoietic stem cell transplantationDonghua Zhang, Lu Zhang, Yi Xiao, et al.Journal of Translational Medicine|June 5, 2025
Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphomaHanyu Wang, Gaoxiang Wang, Tongjuan Li, et al.Expert Review of Hematology|April 14, 2024
Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemiaYizhou Peng, Jinjin Huang, Jin Yin, et al.Cancer Medicine|May 19, 2020
Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemiaXuelian Hu, Haodong Cai, Lu Zheng, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2025
Dasatinib-resistant universal CAR-T cells proliferate in the presence of host immune cells and exhibit antitumor activityYuhang Cheng, Jiayuan Zhang, Wei Mu, et al.Journal for Immunotherapy of Cancer|November 30, 2025
CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicityJia Wu, Jiali Cheng, Li Zhu, et al.Journal of Clinical Immunology|January 3, 2026
TNFRSF13B Variant-Induced TACI Dysregulation Underlies CAEBV PathogenesisXinyue Deng, Qiang Gao, Kefeng Shen, et al.Leukemia|February 23, 2018
ANP32A regulates histone H3 acetylation and promotes leukemogenesisXuejing Yang, Bin Lu, Xueqin Sun, et al.Pageof 9